Medtronic Net Income decreased by 16.8% to $1.14B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 11.7%, from $1.29B to $1.14B. Over 4 years (FY 2021 to FY 2025), Net Income shows an upward trend with a 6.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
The most common metric for evaluating company performance against industry competitors.
net_income| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.36B | $763.00M | $1.31B | $1.48B | $1.49B | $929.00M | $427.00M | $1.22B | $1.18B | $791.00M | $909.00M | $1.32B | $654.00M | $1.04B | $1.27B | $1.29B | $1.06B | $1.04B | $1.37B | $1.14B |
| QoQ Change | — | -43.9% | +71.8% | +12.9% | +0.3% | -37.4% | -54.0% | +186.2% | -3.4% | -33.0% | +14.9% | +45.4% | -50.5% | +59.3% | +21.9% | +1.9% | -18.4% | -1.5% | +32.1% | -16.8% |
| YoY Change | — | — | — | — | +9.2% | +21.8% | -67.4% | -17.4% | -20.5% | -14.9% | +112.9% | +8.2% | -44.6% | +31.7% | +39.7% | -2.1% | +61.5% | -0.2% | +8.2% | -11.7% |